1-8 of 8
Julie M Roda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma

Francesco Di Meo, Anjushree Iyer, Keith Akama, Christina Yu, Rujin Cheng, Annamaria Cesarano, Silvia Marino, Arafat Aljoufi, Rajesh Soni, Julie M Roda, James Sissons, Ly P Vu, Monica L. Guzman, Kun Huang, David G. Roodman, Fabiana Perna
Journal: Blood
Blood (2022) 140 (Supplement 1): 671–672.
https://doi.org/10.1182/blood-2022-167584
Published: 2022
Journal Articles

Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation

Vicky Y Lin, Anjushree Iyer, Keith Akama, Rujin Cheng, Hong Yang, Jonathan Aguayo, Betty Li, Alan K Kutach, Jie Tang, Daniel Kaplan, Julie M Roda
Journal: Blood
Blood (2022) 140 (Supplement 1): 9063–9064.
https://doi.org/10.1182/blood-2022-160209
Published: 2022
Journal Articles

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

Tim D. Eubank, Julie M. Roda, Haowen Liu, Todd O'Neil, Clay B. Marsh
Journal: Blood
Blood (2011) 117 (1): 323–332.
https://doi.org/10.1182/blood-2010-01-261792
Published: 2011
Includes: Supplemental data
Journal Articles

CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody

Farrukh T. Awan, Rosa Lapalombella, Rossana Trotta, Jonathan P. Butchar, Bo Yu, Don M. Benson, Jr, Julie M. Roda, Carolyn Cheney, Xiaokui Mo, Amy Lehman, Jeffrey Jones, Joseph Flynn, David Jarjoura, John R. Desjarlais, Susheela Tridandapani, Michael A. Caligiuri, Natarajan Muthusamy, John C. Byrd
Journal: Blood
Blood (2010) 115 (6): 1204–1213.
https://doi.org/10.1182/blood-2009-06-229039
Published: 2010
Journal Articles

Colocalization of the IL-12 receptor and FcγRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ

Sri Vidya Kondadasula, Julie M. Roda, Robin Parihar, Jianhua Yu, Amy Lehman, Michael A. Caligiuri, Susheela Tridandapani, Richard W. Burry, William E. Carson, III
Journal: Blood
Blood (2008) 111 (8): 4173–4183.
https://doi.org/10.1182/blood-2007-01-068908
Published: 2008
Journal Articles

Pre-Clinical Activity of a Novel FcγRIIIa Engineered CD19 Monoclonal Antibody in B Cell Chronic Lymphocytic Leukemia and Acute Lymphoblastic Leukemia.

Julie M. Roda, Rosa Lapalombella, Robert Baiocchi, Eugene Zhukocsky, John Desjarlais, Natarajan Muthusamy, John C. Byrd
Journal: Blood
Blood (2007) 110 (11): 2351.
https://doi.org/10.1182/blood.V110.11.2351.2351
Published: 2007
Journal Articles

IL-21 Promotes Apoptosis through Induction of the BH3 Only Protein Bim and Enhacnes Direct and Innate Immune-Promoted Death of Chronic Lymphocytic Leukemia Cells.

Julie M. Roda, Aruna Gowda, Rehan Hussain, Asha Ramanunni, Amy Lehman, Wayne Kindsvogel, William E. Carson, Natarajan Muthusamy, John C. Byrd
Journal: Blood
Blood (2007) 110 (11): 3118.
https://doi.org/10.1182/blood.V110.11.3118.3118
Published: 2007
Journal Articles

FcγRIIIa role in rituximab efficacy

Julie M. Roda, John C. Byrd
Journal: Blood
Blood (2007) 110 (7): 2220.
https://doi.org/10.1182/blood-2007-05-090084
Published: 2007